Li-Jiuan Shen, Ph.D. - Publications
Affiliations: | 2004 | University of Southern California, Los Angeles, CA, United States |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Yeh TH, Chen YR, Chen SY, Shen WC, Ann DK, Zaro JL, Shen LJ. Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Molecular Pharmaceutics. PMID 26642391 DOI: 10.1021/Acs.Molpharmaceut.5B00706 | 0.653 | |||
2014 | Wu FL, Yeh TH, Chen YL, Chiu YC, Cheng JC, Wei MF, Shen LJ. Intracellular delivery of recombinant arginine deiminase (rADI) by heparin-binding hemagglutinin adhesion peptide restores sensitivity in rADI-resistant cancer cells. Molecular Pharmaceutics. 11: 2777-86. PMID 24950134 DOI: 10.1021/Mp5001372 | 0.337 | |||
2006 | Shen LJ, Shen WC. Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers. Current Opinion in Molecular Therapeutics. 8: 240-8. PMID 16774044 | 0.422 | |||
2006 | Shen LJ, Beloussow K, Shen WC. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Letters. 231: 30-5. PMID 16356828 DOI: 10.1016/J.Canlet.2005.01.007 | 0.497 | |||
2005 | Shen LJ, Beloussow K, Shen WC. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochemical Pharmacology. 69: 97-104. PMID 15588718 DOI: 10.1016/J.Bcp.2004.09.003 | 0.476 | |||
2003 | Shen LJ, Lin WC, Beloussow K, Hosoya K, Terasaki T, Ann DK, Shen WC. Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochemical Pharmacology. 66: 1945-52. PMID 14599552 DOI: 10.1016/S0006-2952(03)00555-0 | 0.486 | |||
2003 | Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Letters. 191: 165-70. PMID 12618329 DOI: 10.1016/S030-43835(02)00693-6 | 0.51 | |||
Show low-probability matches. |